{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:54:23Z","timestamp":1793105663551,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["ZLRK202301"],"award-info":[{"award-number":["ZLRK202301"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130018"],"award-info":[{"award-number":["82130018"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12072-024-10719-w","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T13:01:45Z","timestamp":1723813305000},"page":"166-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosis"],"prefix":"10.1007","volume":"19","author":[{"given":"Xiaofei","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9409-1158","authenticated-orcid":false,"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"10719_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","volume":"21","author":"G Feng","year":"2024","unstructured":"Feng G, Valenti L, Wong V, Fouad Y, Yilmaz Y, Kim W, et al. Recompensation in cirrhosis: unraveling the evolving natural history of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2024;21:46\u201356","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10719_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 2019;70:531\u2013544","journal-title":"J Hepatol"},{"key":"10719_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71:793\u2013801","journal-title":"J Hepatol"},{"key":"10719_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","volume":"13","author":"S Singh","year":"2015","unstructured":"Singh S, Allen A, Wang Z, Prokop L, Murad M, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13:643\u2013654","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10719_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/apt.15015","volume":"48","author":"J Ampuero","year":"2018","unstructured":"Ampuero J, Aller R, Gallego-Duran R, Banales JM, Crespo J, Garcia-Monzon C, et al. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. Aliment Pharmacol Ther. 2018;48:1260\u20131270","journal-title":"Aliment Pharmacol Ther"},{"key":"10719_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389\u2013397","journal-title":"Gastroenterology"},{"key":"10719_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","volume":"67","author":"H Hagstrom","year":"2017","unstructured":"Hagstrom H, Nasr P, Ekstedt M, Hammar U, Stal P, Hultcrantz R, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 2017;67:1265\u20131273","journal-title":"J Hepatol"},{"key":"10719_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","volume":"155","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology. 2018;155:443\u2013457","journal-title":"Gastroenterology"},{"key":"10719_CR9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.23785","volume":"52","author":"TT Chang","year":"2010","unstructured":"Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, et al. Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010;52:886\u2013893","journal-title":"Hepatology"},{"key":"10719_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson I, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468\u2013475","journal-title":"Lancet"},{"key":"10719_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","volume":"124","author":"I Wanless","year":"2000","unstructured":"Wanless I, Nakashima E, Sherman M. Regression of human cirrhosis morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med. 2000;124:1599\u20131607","journal-title":"Arch Pathol Lab Med"},{"key":"10719_CR12","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/hep.29009","volume":"66","author":"Y Sun","year":"2017","unstructured":"Sun Y, Zhou J, Wang L, Wu X, Chen Y, Piao H, et al. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment. Hepatology. 2017;66:1438\u20131450","journal-title":"Hepatology"},{"key":"10719_CR13","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41379-018-0059-x","volume":"31","author":"B Wang","year":"2018","unstructured":"Wang B, Sun Y, Zhou J, Wu X, Chen S, Wu S, et al. Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients. Mod Pathol. 2018;31:1567\u20131577","journal-title":"Mod Pathol"},{"key":"10719_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367\u2013378","journal-title":"Gastroenterology"},{"key":"10719_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease:practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67:328\u2013357","journal-title":"Hepatology"},{"key":"10719_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57\u201363","journal-title":"Diabetes Care"},{"key":"10719_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","volume":"48","author":"L Castera","year":"2008","unstructured":"Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835\u2013847","journal-title":"J Hepatol"},{"key":"10719_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ, Paredes A, Boursier J, Chan WK, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020;5:362\u2013373","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10719_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","volume":"76","author":"M Noureddin","year":"2021","unstructured":"Noureddin M, Truong E, Gornbein JA, Saouaf R, Guindi M, Todo T, et al. MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis. J Hepatol. 2021;76:781\u2013787","journal-title":"J Hepatol"},{"key":"10719_CR20","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1038\/s41598-018-21179-2","volume":"8","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zhou J, Wu X, Chen Y, Piao H, Lu L, et al. Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak \u201cstable\u201d patients on anti-HBV therapy. Sci Rep. 2018;8:2989","journal-title":"Sci Rep"},{"key":"10719_CR21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41379-018-0048-0","volume":"31","author":"ND Theise","year":"2018","unstructured":"Theise ND, Jia J, Sun Y, Wee A, You H. Progression and regression of fibrosis in viral hepatitis in the treatment era: the Beijing classification. Mod Pathol. 2018;31:1191\u20131200","journal-title":"Mod Pathol"},{"key":"10719_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","volume":"20","author":"DE Kleiner","year":"2016","unstructured":"Kleiner DE, Makhlouf HR. Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children. Clin Liver Dis. 2016;20:293\u2013312","journal-title":"Clin Liver Dis"},{"key":"10719_CR23","doi-asserted-by":"publisher","first-page":"12414","DOI":"10.1038\/s41598-018-30457-y","volume":"8","author":"Y Luo","year":"2018","unstructured":"Luo Y, Oseini A, Gagnon R, Charles ED, Sidik K, Vincent R, et al. An evaluation of the collagen fragments related to fibrogenesis and fibrolysis in nonalcoholic steatohepatitis. Sci Rep. 2018;8:12414","journal-title":"Sci Rep"},{"key":"10719_CR24","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/ar.23567","volume":"300","author":"KM Mak","year":"2017","unstructured":"Mak KM, Mei R. Basement membrane type IV collagen and laminin an overview of their biology and value. Anat Rec. 2017;300:1371\u20131390","journal-title":"Anat Rec"},{"key":"10719_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cld.2008.07.008","volume":"12","author":"RG Wells","year":"2008","unstructured":"Wells RG. Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis. 2008;12:759\u2013768","journal-title":"Clin Liver Dis"},{"key":"10719_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/hepr.13857","volume":"53","author":"Y Honda","year":"2023","unstructured":"Honda Y, Yoneda M, Kobayashi T, Iwaki M, Kawamura N, Nogami A, et al. Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease. Hepatol Res. 2023;53:219\u2013227","journal-title":"Hepatol Res"},{"key":"10719_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/hep4.1637","volume":"5","author":"H Ishiba","year":"2021","unstructured":"Ishiba H, Sumida Y, Seko Y, Tanaka S, Yoneda M, Hyogo H, et al. Type IV collagen 7S is the most accurate test for identifying advanced fibrosis in NAFLD with type 2 diabetes. Hepatol Commun. 2021;5:559\u2013572","journal-title":"Hepatol Commun"},{"key":"10719_CR28","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1007\/s11010-021-04216-z","volume":"476","author":"S Appunni","year":"2021","unstructured":"Appunni S, Rubens M, Ramamoorthy V, Anand V, Khandelwal M, Sharma A. Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance. Mol Cell Biochem. 2021;476:3935\u20133950","journal-title":"Mol Cell Biochem"},{"key":"10719_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/liv.15477","volume":"43","author":"M Yu","year":"2022","unstructured":"Yu M, He X, Song X, Gao J, Pan J, Zhou T, et al. Biglycan promotes hepatic fibrosis through activating heat shock protein 47. Liver Int. 2022;43:500\u2013512","journal-title":"Liver Int"},{"key":"10719_CR30","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/hep.31995","volume":"74","author":"K Kozumi","year":"2021","unstructured":"Kozumi K, Kodama T, Murai H, Sakane S, Govaere O, Cockell S, et al. Transcriptomics identify thrombospondin-2 as a biomarker for NASH and advanced liver fibrosis. Hepatology. 2021;74:2452\u20132466","journal-title":"Hepatology"},{"key":"10719_CR31","doi-asserted-by":"publisher","first-page":"G744","DOI":"10.1152\/ajpgi.00339.2018","volume":"316","author":"W Chen","year":"2019","unstructured":"Chen W, Wu X, Yan X, Xu A, Yang A, You H. Multitranscriptome analyses reveal prioritized genes specifically associated with liver fibrosis progression independent of etiology. Am J Physiol Gastrointest Liver Physiol. 2019;316:G744\u2013G754","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10719_CR32","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s12072-019-09982-z","volume":"13","author":"Q Wang","year":"2019","unstructured":"Wang Q, You H, Ou X, Zhao X, Sun Y, Wang M, et al. Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis. Hep Int. 2019;13:766\u2013776","journal-title":"Hep Int"},{"key":"10719_CR33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/hep.510290307","volume":"29","author":"M Yasuda","year":"1999","unstructured":"Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology. 1999;29:719\u2013727","journal-title":"Hepatology"},{"key":"10719_CR34","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.26761","volume":"59","author":"J Yang","year":"2014","unstructured":"Yang J, Abdelmalek M, Pang H, Guy C, Smith A, Diehl A, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology. 2014;59:1406\u20131414","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10719-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10719-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10719-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:45:04Z","timestamp":1740210304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10719-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10719"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10719-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4392304\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted by the principles enshrined in the Declaration of Helsinki and the Good Clinical Practices. The Ethics Committee of Beijing Friendship Hospital, Capital Medical University approved the study protocol (Approval No. 2015-P2-070\u201301).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients gave written informed consent prior to their enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors had access to the study data and reviewed and approved the final manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}